221 related articles for article (PubMed ID: 29568881)
1. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G
Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.
Wu YR; Shi XY; Ma CY; Zhang Y; Xu RX; Li JJ
Cardiovasc Diabetol; 2019 Nov; 18(1):146. PubMed ID: 31706303
[TBL] [Abstract][Full Text] [Related]
5. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1166-76. PubMed ID: 22967502
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/
Yu J; Zhao Y; Xu L; Li W; Zhang H; Ping F; Li Y
Mediators Inflamm; 2023; 2023():8974960. PubMed ID: 36756089
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice.
Chen LN; Lyu J; Yang XF; Ji WJ; Yuan BX; Chen MX; Ma X; Wang B
Int J Mol Med; 2013 Oct; 32(4):892-900. PubMed ID: 23877319
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
Yang SH; Xu RX; Cui CJ; Wang Y; Du Y; Chen ZG; Yao YH; Ma CY; Zhu CG; Guo YL; Wu NQ; Sun J; Chen BX; Li JJ
Cardiovasc Diabetol; 2018 Apr; 17(1):48. PubMed ID: 29618348
[TBL] [Abstract][Full Text] [Related]
9. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
You HN; Park MH; Hwang SY; Han JS
J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
[TBL] [Abstract][Full Text] [Related]
10. Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.
Liu J; Yang K; Yang J; Xiao W; Le Y; Yu F; Gu L; Lang S; Tian Q; Jin T; Wei R; Hong T
EBioMedicine; 2019 Mar; 41():73-84. PubMed ID: 30827929
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway.
Li Y; Fu H; Wang H; Luo S; Wang L; Chen J; Lu H
Mol Cell Endocrinol; 2020 Sep; 515():110921. PubMed ID: 32615283
[TBL] [Abstract][Full Text] [Related]
12. Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity.
Liang Y; Li Z; Liang S; Li Y; Yang L; Lu M; Gu HF; Xia N
Nutr Diabetes; 2016 Jan; 6(1):e191. PubMed ID: 26807509
[TBL] [Abstract][Full Text] [Related]
13. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
14. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
15. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
[TBL] [Abstract][Full Text] [Related]
16. Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling.
Kim MH; Jee JH; Park S; Lee MS; Kim KW; Lee MK
J Endocrinol; 2014 Feb; 220(2):117-28. PubMed ID: 24233023
[TBL] [Abstract][Full Text] [Related]
17. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
Choi HE; Kim Y; Lee HJ; Cheon HG
Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
[TBL] [Abstract][Full Text] [Related]
18. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
Lampropoulou E; Lymperopoulou A; Charonis A
Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
[TBL] [Abstract][Full Text] [Related]
20. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice.
Yan F; Dai G; Zheng X
J Nutr Biochem; 2016 Oct; 36():68-80. PubMed ID: 27580020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
